Biomarkers – News and Features

This article explores how next-generation sequencing has revolutionized microbiome research, enabling comprehensive analysis of microbial communities and their roles in health and disease.

A study suggests that individuals with less diverse oral microbiomes are more likely to report symptoms of depression. The research highlights the potential link between oral health and mental well-being.

People whose gut microbiomes produce a lot of methane are especially good at unlocking extra energy from a high-fiber diet. This may help explain why different individuals obtain different amounts of calories from food that reaches the colon.

The findings showed that eating 2 ounces of almonds – about 45 nuts – daily led to signs of better cardiometabolic and gut health.

Computed tomography (CT) colonography is a more cost-effective and more clinically effective method for colorectal cancer screening compared to stool DNA testing (mt-sDNA), a new study suggests.

A series of digital tests, carried out via a smartphone app, could enhance the detection of disease progression in Huntington’s disease and improve the efficiency of clinical trials.

Researchers have discovered a novel biomarker for severe multiple sclerosis (MS). This research will contribute to our understanding of the molecular processes involved in progressive MS, and may aid in the allocation of patients to novel therapies.

Dr. John Beeler, BPGbio, discusses why investing in biology is essential for AI-driven drug discovery and for building a more sustainable, cost-effective healthcare system worldwide.

Researchers have discovered inherited genetic differences which could explain why some patients with the deadliest form of skin cancer do not respond to the latest cancer treatments.

Researchers have developed the Krakencoder, a new tool that integrates structural and functional brain data to predict cognitive performance and behavior more accurately. The tool could enhance understanding of brain networks.